DTIL - Precision BioSciences, Inc. -  [ ]

Ticker Details
Precision BioSciences, Inc.
IPO Date: May 25, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $186.55M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.24 | 3.67%
Avg Daily Range (30 D): $0.24 | 3.22%
Avg Daily Range (90 D): $0.20 | 3.53%
Institutional Daily Volume
Avg Daily Volume: .52M
Avg Daily Volume (30 D): .2M
Avg Daily Volume (90 D): .23M
Trade Size
Avg Trade Size (Sh.): 150
Avg Trade Size (Sh.) (30 D): 62
Avg Trade Size (Sh.) (90 D): 78
Institutional Trades
Total Institutional Trades: 326
Avg Institutional Trade: $1.4M
Avg Institutional Trade (30 D): $.82M
Avg Institutional Trade (90 D): $.82M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.54M
Avg Closing Trade (30 D): $.82M
Avg Closing Trade (90 D): $.82M
Avg Closing Volume: 9.61K
 
News
Jan 22, 2026 @ 9:56 AM
Genome Editing Market Forecast to Reach $23.6 Bill...
Source: Researchandmarkets.Com
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
Sep 10, 2024 @ 9:00 AM
Global Genetic Engineering Market Size To Worth US...
Source: Spherical Insights & Consulting
Sep 10, 2024 @ 8:51 AM
Gene Editing Therapeutics Market Forecast 2024-202...
Source: Researchandmarkets.Com
May 29, 2024 @ 1:55 PM
Does Precision BioSciences (DTIL) Have the Potenti...
Source: Zacks Equity Research
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-2.14 $-.75 $2.58
Diluted EPS $-2.14 $-.75 $2.58
Revenue $45.07M $10.84M $34.2M
Gross Profit
Net Income / Loss $-43.6M $-18.44M $20.13M
Operating Income / Loss $-39.11M $-9.08M $12.51M
Cost of Revenue
Net Cash Flow $26.06M $-11.31M $65.94M
PE Ratio    
Splits
Feb 14, 2024 1:30